RxDoctor Payments Data

Taylor Lightsey

Family · Birmingham, ALNPI 1255058764

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations.

$2,520in general payments, 2019–2025

Across 129 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$455
  • AstraZeneca$383
  • Novo Nordisk$355
  • Corcept Therapeutics$184
  • Ardelyx, Inc.$161
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$146
  • plus $836 from 16 others

What the payments were for

  • Food & beverage$2,520100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,520 in reported general payments places this provider in the 80th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama →

Other family in Birmingham

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →